Spectral AI, Inc.

Q2 2026 revenue was $3.5 million, down from $5.1 million in Q2 2025. Gross margin was 31.6% versus 45.2% a year ago, and for the first six months gross margin was 41.8% versus 46.4%. R&D expense was $1.7 million, sales and marketing was $700,000, and general and administrative was $3.1 million. Net loss was $4.2 million, or $0.13 per share, versus a net loss of $8.0 million, or $0.31 per share, in Q2 2025. Management reiterated full-year 2026 revenue guidance of approximately $18.5 million, including the effect of new BARDA funding from March, and said that guidance excludes any significant DeepView system sales.

Vincent Capone said the FDA de novo clearance validates the science and marks a shift from a development company to a commercial organization. He emphasized a disciplined rollout focused on burn centers first, then broader expansion across the U.S. and select international markets, while also building out additional indications and a platform technology strategy. His tone was optimistic and energized, but he repeatedly tied that optimism to execution on procurement, commercialization infrastructure, and clinical relationships.

David McGuire described Q2 as transitional, with revenue down because BARDA work moved into a cost-sharing phase and the company was between major study phases. He said the lower gross margin of 31.6% reflected that cost share, while the commercial model should eventually support better margins because it combines device placement with recurring software and service revenue on minimum three-year terms. He noted cash of $14 million at June 30, 2026, total debt of $14.9 million, the $6.5 million second tranche draw on the Avenue Capital facility, no principal payments until March 2027, and continued access to BARDA funding and the Yorkville equity facility if needed.

Analysts focused on the commercial ramp: how many salespeople Spectral needs, what the rollout timeline looks like, and what barriers could slow deployment. Management said the current sales force is two people, plus at least two more budgeted hires, and said some sites will move quickly because of existing KOL relationships while others will take longer due to procurement, cybersecurity, and AI committee reviews. Questions also covered the handheld prototype and international expansion; management said the MTEC prototype work is complete, further government funding is possible but uncertain, and the first international installs are expected to be in the U.K. and Australia, with other geographies possible later.